A freelance medical writer, columnist and author of the book, Living with Multiple Myeloma, Pat understood how the stem cell transplant process worked. Even so, he was still apprehensive about what to expect when he underwent an autologous stem cell transplant during the summer of 2011 at Moffitt Cancer Center in Tampa, Florida. When one of his readers suggested that Pat write a book about his experience, Pat enthusiastically embraced the project.
The goal: To help give future stem cell transplant patients a roadmap for success.
Pat immediately began interviewing former stem cell transplant recipients, asking them to share the things they wish they would have known before they started. Stem Cell Transplants from a Patient’s Perspective is filled with tips and advice from those who know best: the patients themselves. A must read for anyone who might need a stem cell transplant.
Stem cell based therapy is a 21st century approach of therapeutic intervention which epitomizes a shift from conventional symptomatic treatment strategy to addressing the root cause of the disease process. This is especially a hope for the patients suffering from diseases such as Alzheimer, diabetes, myocardial infarction and other diseases which have always been considered as incurable. Moreover, stem cells provide excellent in vitro disease models for drug development. This book is a compilation of the bench experience of experts from various research labs involved in the cutting edge area of research, describing the use of stem cells both as part of the combinatorial therapeutic intervention approach and as tools (disease model) during drug development.
In excess of 7 million people worldwide die of coronary heart disease each year. Only one-third of these heart attack victims recover completely. The remainder suffer the consequences of myocardial infarction and its ill fated remodeling process, resulting in chronic congestive heart failure. This malady alone is the leading cause of hospital admissions in the United States.
New breakthroughs in stem cell therapy and tissue engineering have promised to reverse this dismal outcome by cardiovascular repair. World authorities, including scientists and regulatory authorities, have joined in a collaborative effort to present for the reader the first collective review of stem cell therapy for the treatment of cardiovascular disease. These contributions in basic science, pre-clinical and clinical experience guided by the regulatory pathways, assure a rapid course of translational research and clinical trials.
The contents of this publication will become a prerequisite for those preparing to meet the challenges of this exciting and potentially rewarding field of stem cell research.